Published 2 days ago • loading... • Updated 11 hours ago

The Future of Made-in-Montana Energy

Piramal Pharma Solutions reported an industry-leading NPS of 55, as announced by the company, reflecting its commitment to patient and customer centricity.
Piramal Pharma Solutions credits the score to its Patient, Customer and Consumer Centricity, saying cross-department collaboration, transparency and accountability underpin performance across its global network.
Annual customer and promoter surveys coordinated by the Customer Centricity team are presented to the Board of Directors and assured by DNV in the Sustainability Report.
The result reinforces PPS's market leadership against competitors as the NPS of 55 far exceeded average negative scores reported by competitor CDMOs, with Peter DeYoung, CEO, saying it will guide strategic initiatives to enhance client engagement and operational efficiency.
With 17 global development and manufacturing facilities and distribution network in over 100 countries, the validated score matters commercially as survey insights inform Piramal Pharma Ltd. 's organizational strategic initiatives.

Insights by Ground AI

34 Articles

keenesentinel.com

+33 Reposted by 33 other sources

Center

Piramal Pharma Solutions Demonstrates Commitment to Excellence with Outstanding Net Promoter Score

Piramal Pharma Solutions recently achieved a net promoter score (NPS) of 55, far surpassing industry averages.A third-party provider, DNV, validated the NPS survey and score.This accomplishment reflects the Organization's dedication to stakeholder centricity and operational excellence.

2 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year